Adjuvant Hormonotherapy and Cardiovascular Risk in Post-Menopausal Women with Breast Cancer: A Large Population-Based Cohort Study

SIMPLE SUMMARY: For post-menopausal women with estrogen-receptor-positive breast cancer, treatment with aromatase inhibitors reduces disease recurrence and mortality, as compared to tamoxifen. Nevertheless, women treated with aromatase inhibitors more often develop hyperlipidemia, hypercholesterolem...

Descripción completa

Detalles Bibliográficos
Autores principales: Franchi, Matteo, Tritto, Roberta, Tarantini, Luigi, Navazio, Alessandro, Corrao, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125834/
https://www.ncbi.nlm.nih.gov/pubmed/34066685
http://dx.doi.org/10.3390/cancers13092254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125834/
https://www.ncbi.nlm.nih.gov/pubmed/34066685
http://dx.doi.org/10.3390/cancers13092254

Ejemplares similares